litlas
Log inCreate account

David L. Nelson

Active 1974–2024

Also published as
DAVID L. NELSON
164
Papers
36,482
Citations
107
h-index
162
i10-index

Citations

Citations per year for David L. Nelson1955: 1 citations1976: 5 citations1977: 6 citations1978: 21 citations1979: 16 citations1980: 24 citations1981: 22 citations1982: 24 citations1983: 25 citations1984: 35 citations1985: 41 citations1986: 51 citations1987: 53 citations1988: 68 citations1989: 74 citations1990: 87 citations1991: 106 citations1992: 157 citations1993: 262 citations1994: 226 citations1995: 225 citations1996: 233 citations1997: 215 citations1998: 176 citations1999: 178 citations2000: 243 citations2001: 265 citations2002: 272 citations2003: 287 citations2004: 300 citations2005: 272 citations2006: 264 citations2007: 282 citations2008: 310 citations2009: 299 citations2010: 320 citations2011: 339 citations2012: 275 citations2013: 299 citations2014: 288 citations2015: 223 citations2016: 178 citations2017: 197 citations2018: 210 citations2019: 533 citations2020: 549 citations2021: 465 citations2022: 366 citations2023: 265 citations2024: 429 citations2025: 165 citations2026: 4 citations1956–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,112 citing papers, 37.7% of this breakdownUnited Kingdom: 785 citing papers, 7.2% of this breakdownGermany: 583 citing papers, 5.3% of this breakdownFrance: 576 citing papers, 5.3% of this breakdownChina: 463 citing papers, 4.2% of this breakdownCanada: 432 citing papers, 4% of this breakdownItaly: 428 citing papers, 3.9% of this breakdownJapan: 367 citing papers, 3.4% of this breakdownNetherlands: 363 citing papers, 3.3% of this breakdownAustralia: 268 citing papers, 2.5% of this breakdownSwitzerland: 192 citing papers, 1.8% of this breakdownSpain: 186 citing papers, 1.7% of this breakdown
0%37.7%Other 19.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology44%
  • Medicine21.8%
  • Neuroscience17%
  • Immunology and Microbiology7.7%
  • Environmental Science2.3%
  • Computer Science1.8%
  • Other5.4%

Topics

  • Genetics and Neurodevelopmental Disorders7.5%
  • Autism Spectrum Disorder Research3.4%
  • Genetic Neurodegenerative Diseases2.7%
  • RNA Research and Splicing2.1%
  • RNA modifications and cancer2%
  • Mitochondrial Function and Pathology1.8%
  • Other80.5%

Coauthors

All papers

Open in search
  1. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

    Authors: Annemieke J.M.H. Verkerk, Maura Pieretti, James S. Sutcliffe, Ying‐Hui Fu, Derek P.A. Kuhl, Antonio Pizzuti, Orly Reiner, Stephen Richards, M F Victoria, Fuping Zhang, Bert E. Eussen, Gert‐Jan B. van Ommen, Lau A.J. Blonden, Gregory J. Riggins, Jane L. Chastain, Catherine B. Kunst, H. Galjaard, C. Thomas Caskey, David L. Nelson, Ben A. Oostra, Stephen T. Warren - Cell 1991 cited by 3,524

  2. Characterization and visualization of tandem repeats at genome scale

    Authors: Egor Dolzhenko, Adam C. English, Harriet Dashnow, Guilherme De Sena Brandine, Tom Mokveld, William J. Rowell, Caitlin Karniski, Zev Kronenberg, Matt C. Danzi, Warren Cheung, Chengpeng Bi, Emily Farrow, Aaron M. Wenger, Khi Pin Chua, Verónica Martínez‐Cerdeño, Trevor D. Bartley, Peng Jin, David L. Nelson, Stephan Züchner, Tomi Pastinen, Aaron R. Quinlan, Fritz J. Sedlazeck, Michael A. Eberle - Nature Biotechnology 2024 cited by 125

  3. LLPS of FXR1 drives spermiogenesis by activating translation of stored mRNAs

    Authors: Jun-Yan Kang, Ze Wen, Duo Pan, Yuhan Zhang, Qing Li, Ai Zhong, Xinghai Yu, Yichen Wu, Yu Chen, Xiangzheng Zhang, Peng-Cheng Kou, Junlan Geng, Yingyi Wang, Min-Min Hua, Rui-Ting Zong, Biao Li, Huijuan Shi, Dangsheng Li, Xiang‐Dong Fu, Jinsong Li, David L. Nelson, Xuejiang Guo, Yu Zhou, Lan‐Tao Gou, Ying Huang, Mo‐Fang Liu - Science 2022 cited by 181

  4. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

    Authors: Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, Joël Bockaert, Michael Camilleri, Séverine Chaumont‐Dubel, Sylvie Claeysen, Kathryn A. Cunningham, K.C.F. Fone, Michael D. Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel Hartley, Ghérici Hassaı̈ne, Katharine Herrick‐Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman‐Tancredi, Hugues Nury, A Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts, Daniël Hoyer - Pharmacological Reviews 2020 cited by 260

  5. Absence of expression of the FMR-1 gene in fragile X syndrome

    Authors: Maura Pieretti, Fuping Zhang, Ying‐Hui Fu, Stephen T. Warren, Ben A. Oostra, C. Thomas Caskey, David L. Nelson - Cell 1991 cited by 1,485

  6. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

    Authors: Yansheng Du, Zhizhong Ma, Suizhen Lin, Richard Dodel, Feng Gao, Kelly R. Bales, Lazarose C. Triarhou, Eyassu Chernet, Ken Perry, David L. Nelson, Susan Luecke, Lee A. Phebus, Frank P. Bymaster, Steven M. Paul - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 786

  7. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence

    Authors: Hsun-Hua Chou, Hiromu Takematsu, Sandra Diaz, Jane Iber, Elizabeth Nickerson, Kerry L. Wright, Elaine A. Muchmore, David L. Nelson, Stephen T. Warren, Ajit Varki - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 583

  8. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox

    Authors: Ying‐Hui Fu, Derek P.A. Kuhl, Antonio Pizzuti, Maura Pieretti, James S. Sutcliffe, Stephen Richards, Annemieke J.M.H. Verkert, Jeanette J. A. Holden, Raymond G. Fenwick, Stephen T. Warren, Ben A. Oostra, David L. Nelson, C. Thomas Caskey - Cell 1991 cited by 2,101

  9. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo

    Authors: Edwin Mientjes, Ingeborg M. Nieuwenhuizen, Laura Kirkpatrick, Tao Zu, Marianne Hoogeveen‐Westerveld, LA Severijnen, M. Rifé, Rob Willemsen, David L. Nelson, Ben A. Oostra - Neurobiology of Disease 2005 cited by 291

  10. Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome

    Authors: Jonathan W. Lovelace, Maham Rais, Arnold R. Palacios, Xinghao Steven Shuai, Steven Bishay, Otilia Popa, Patricia S. Pirbhoy, Devin K. Binder, David L. Nelson, Iryna M. Ethell, Khaleel A. Razak - Cerebral Cortex 2019 cited by 87

  11. Intercepting IRE1 kinase‐FMRP signaling prevents atherosclerosis progression

    Authors: Zehra Yıldırım, Sabyasachi Baboo, Syed Muhammad Hamid, Asli E. Atici, Özlem Tufanlı, Sabrina Robichaud, Christina Emerton, Jolene K. Diedrich, Hasan Vatandaslar, Fotis Nikolos, Yanghong Gu, Takao Iwawaki, Elizabeth J. Tarling, Mireille Ouimet, David L. Nelson, John R. Yates, Peter Walter, Ebru Erbay - EMBO Molecular Medicine 2022 cited by 36

  12. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration

    Authors: Zihui Xu, Mickaël Poidevin, Xuekun Li, Yujing Li, Liqi Shu, David L. Nelson, He Li, Chadwick M. Hales, Marla Gearing, Thomas S. Wingo, Peng Jin - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 341

  13. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo

    Authors: Haruki Higashimori, Christina Schin, Ming Sum Ruby Chiang, Lydie Morel, Temitope Shoneye, David L. Nelson, Y. Yang - Journal of Neuroscience 2016 cited by 108

  14. Length of uninterrupted CGG repeats determines instability in the FMR1 gene

    Authors: Evan E. Eichler, Jeanette J. A. Holden, Bradley W. Popovich, Allan L. Reiss, Karen Snow, Stephen N. Thibodeau, C. Sue Richards, Patricia A. Ward, David L. Nelson - Nature Genetics 1994 cited by 482

  15. Bmal1 and β-Cell Clock Are Required for Adaptation to Circadian Disruption, and Their Loss of Function Leads to Oxidative Stress-Induced β-Cell Failure in Mice

    Authors: Jeongkyung Lee, Mousumi Moulik, Zhe Fang, Pradip Saha, Fang Zou, Yong Xu, David L. Nelson, Ke Ma, David D. Moore, Vijay Yechoor - Molecular and Cellular Biology 2013 cited by 216

  16. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.

    Authors: Michael P. Johnson, Richard J. Loncharich, M Baez, David L. Nelson - Molecular Pharmacology 1994 cited by 107

  17. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

    Authors: Laurence A. Rubin, Carole C. Kurman, M E Fritz, William E. Biddison, Bernard Boutin, Robert Yarchoan, David L. Nelson - The Journal of Immunology 1985 cited by 1,159

  18. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10

    Authors: Tohru Matsuura, Takanori Yamagata, Daniel L. Burgess, Astrid Rasmussen, Raji P. Grewal, Kei Watase, Mehrdad Khajavi, Alanna E. McCall, Caleb Davis, Lan Zu, Madhureeta Achari, Stefan M. Pulst, Elisa Alonso, Jeffrey L. Noebels, David L. Nelson, Huda Y. Zoghbi, Tetsuo Ashizawa - Nature Genetics 2000 cited by 513

  19. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome

    Authors: Carolyn M. Yrigollen, Blythe Durbin‐Johnson, Louise W. Gane, David L. Nelson, Randi J. Hagerman, Paul J. Hagerman, Flora Tassone - Genetics in Medicine 2012 cited by 178

  20. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors

    Authors: David L. Nelson, Virginia L. Lucaites, David B. Wainscott, Richard A. Glennon - Naunyn-Schmiedeberg s Archives of Pharmacology 1999 cited by 135

  21. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti

    Authors: Asma Smahi, P. Vabres, S. Heuertz, A Munnich, Gilles Courtois, Shoji Yamaoka, Alain Israël, Nina S. Heiss, Sabine M. Klauck, Petra Kioschis, Stefan Wiemann, Annemarie Poustka, Teresa Esposito, Tiziana Bardaro, Fernando Gianfrancesco, Alfredo Ciccodicola, Michele D’Urso, Hayley Woffendin, Tracy Jakins, Susan Kenwrick, Dian Donnai, Helen Stewart, Swaroop Aradhya, Richard A. Lewis, David L. Nelson, Moise L. Levy, T Yamagata - Nature 2000 cited by 748

  22. DNA methylation represses FMR-1 transcription in fragile X syndrome

    Authors: James S. Sutcliffe, David L. Nelson, Fuping Zhang, Maura Pieretti, C. Thomas Caskey, Debra Saxe, Stephen T. Warren - Human Molecular Genetics 1992 cited by 681

  23. Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome

    Authors: Sebastiaan K. E. Koekkoek, Kazuhiko Yamaguchi, Bogdan Milojkovic, Bjorn Dortland, Tom J. H. Ruigrok, Reinoud Maex, Wilmar de Graaf, Albertine Smit, Frans VanderWerf, C.E. Bakker, Rob Willemsen, Toshio Ikeda, Sho Kakizawa, Koun Onodera, David L. Nelson, Edwin Mientjes, Marieke Joosten, Erik De Schutter, Ben A. Oostra, M. Ito, Chris I. De Zeeuw - Neuron 2005 cited by 409

  24. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency

    Authors: Qiang Pan‐Hammarström, Ulrich Salzer, Likun Du, Janne Björkander, Charlotte Cunningham‐Rundles, David L. Nelson, Chiara Bacchelli, H. Bobby Gaspar, Steven M. Offer, Timothy W. Behrens, Bodo Grimbacher, Lennart Hammarström - Nature Genetics 2007 cited by 239